By last November, 12% of U.S. adults were already taking a glucagon-like peptide 1 (GLP-1) medication for various reasons, per a Kaiser Family Foundation poll. This week, it just became easier to take ...

The weight-loss drug Wegovy is now being sold in pill form, an advancement that allows users to transition away from weekly injections. It's the first GLP-1 weight-loss medication to become available ...

The GLP-1 medication is now available via injection and pill.

Add Yahoo as a preferred source to see more of our stories on Google. Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on Friday, March 1, 2024. ...

Add Yahoo as a preferred source to see more of our stories on Google. Novo Nordisk’s oral semaglutide. (Novo Nordisk/FDA) Americans now have access to the pill form of weight loss medication Wegovy, ...

For years, pharmaceutical companies have been racing to develop a market-ready GLP-1 weight-loss pill to join the ranks of popular injectables. Today, Novo Nordisk’s oral version of Wegovy is ...

The U.S. Food and Drug Administration approved a once-daily pill version of Novo Nordisk’s blockbuster GLP-1 weight loss drug Wegovy. The FDA made the decision Dec. 22. The starting dose of 1.5 ...

NEW YORK — A new pill form of the weight-loss drug Wegovy is now available to people in the United States, giving adults a daily tablet option instead of a weekly injection, health officials and the ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...